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Redox homeostasis is essential for normal function of cells and redox imbalance has been
recognised as a pathogenic factor of numerous human diseases. Oxidative modifications of
cysteine thiols modulate function of many proteins, mediate signalling, and fine-tune
transcriptional andmetabolic processes. In this study we present the SNO/SOH TMT strategy,
which enables simultaneous analysis of two different types of cysteine modification:
S-nitrosylation (SNO) and S-sulfenylation (SOH). The method facilitates quantitation of
modification changes corrected by changes in protein abundance levels and estimation of
relativemodification site occupancy in a single nLC-MSMS run. The approachwas evaluated in
vivo using an Escherichia coli based model of mild oxidative stress. Bacteria were grown
anaerobically on fumarate or nitrate. Short-term treatment with sub-millimolar levels of
hydrogen peroxide was used to induce SOH. We have identified and quantified 114 SNO and
SOHmodified peptides. In many instances SNO and SOH occupy the same site, suggesting an
association between them.High site occupancydoesnot equate to a site ofmodificationwhich
responds to redox imbalance. The SNO/SOH TMT strategy is a viable alternative to existing
methods for cysteine oxidation analysis and provides new features that will facilitate our
understanding of the interplay between SNO and SOH.
Biological significance
SNO/SOH TMT strategy outperforms other available strategies for cysteine oxidation
analysis. It provides quantitative profiling of S-nitrosylation and S-sulfenylation changes
simultaneously in two experimental conditions. It allows correction of modification levels
by protein abundance changes and determination of relative modification site occupancy—
all in a single nLC-MSMS experiment based on commercially available reagents. The
method has proven precise and sensitive enough to detect and quantify endogenous levels
of oxidative stress on proteome-wide scale.
© 2014 Elsevier B.V. All rights reserved.
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1. Introduction
Cellular thiol redox state is a crucial mediator of multiple
metabolic, signalling, and transcriptional processes in cells.
Balance between oxidising and reducing conditions is essential
for thenormal function and survival of cells. Oxidative stress has
been recognised as pathogenic and etiological factor of numer-
ous human diseases, including cancer, diabetes, atherosclerosis,
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cardiovascular and neurodegenerative diseases [1]. It is also
involved in physiological ageing anddegenerative processes that
occur in age-related diseases. Protein thiols, due to their ability
to be reversibly oxidised, are recognised as key components
involved in the maintenance of redox homeostasis [2]. There
are 7 recognised oxidative modifications of cysteine, 5 of which
are reversible [2]. Among these, S-nitrosylation (SNO) and
S-sulfenylation (SOH) play a significant role in regulating cellular
signalling in response to redox imbalance. SNO is a covalent
additionof nitroso grouponto the reduced thiol of cysteine's side
chain. Endogenous sources of nitroso group are for instance, the
nitric oxide synthase (NOS) family of enzymes [3]. There are
representatives of the NOS family in almost every cell type
(neuronal nNOS/NOS1, endothelial eNOS/NOS3, inducible/Ca2+-
independent iNOS/NOS2) [3]. Indirectly, SNO may also occur via
contact with existing nitrosylated proteins that act as nitroso
group donors, in a process termed trans-nitrosylation [4]. SOH is
an oxidation of the cysteine sulfhydryl to sulfenic acid. The
major inducer of SOH is hydrogen peroxide (H2O2), which is
generated in the cell e.g., as a product of superoxide dismutase
catalytic activity [5].
SNO and SOH do not occur equally over all cysteine
residues due to the variable electronegativity of cysteine in
biological systems. This, combined with their transient nature
makes them excellent signalling mediators [1]. For example,
in Escherichia coli grown anaerobically on nitrate, SNO of
OxyR initiates a signalling cascade activating mechanisms
protecting against endogenous nitrosative stress [6]. Antiox-
idant buffering capacity is also an important function of SNO.
Elevated levels of SNO during ischemic preconditioning
prevent build-up of irreversible protein oxidations helping to
guard against irreversible oxidative damage during reperfu-
sion [4]. SOH is known to function as a transient intermediate
in the formation ofmore stable cysteine oxidation products [7]
and it is an indicator of oxidant-sensitive cysteines and
potentially also of severe oxidative damage [8]. It is implicated
in redox regulation of transcription factors [9]. Protein SOH
can modify the activity of enzymes [10,11] and act as an
initiator of disulfide bond formation [12].
For effective analysis of SNO and SOH selective labelling and
enrichment are required [13]. A number ofmethods for analysis
of cysteine oxidation exist, each with certain advantages and
limitations, as reviewed in [2]. Themajority of strategies used in
the analysis of protein SNO, are variations of the biotin switch
technique [14]. The most advanced of these provide precise
localisation of modification site and its relative abundance
[15–17]. Biotin switch has also been adapted for analysis of
cysteine SOH [18]. However, dimedone labelling is more
widespread [19,20]. Recently, new cell-permeable analogues of
dimedone have been developed which significantly shortens
the time for sulfenic acid selective capture thus minimising
artifactual results [21,22].
Despite dynamic advances in molecular biology and mass
spectrometry-based strategies for analysis of cysteine redox
proteomes there remain several challenges. The majority of
current methods provide quantitative information, yet, cor-
rection of modification levels by protein abundance changes
is still a rare practise. In fact there are only few existing
methods which either inherently correct observed modifica-
tion levels in such a way [15], or with additional workload
provide such correction [23–25]. However, all of these ap-
proaches use non-isobaric isotopic labels which suffer from
low throughput due to increased sample complexity, limited
dynamic range of quantitation and typically can target only 2
samples/conditions due to isotopic limitations. An additional
layer of quantitative information relevant for determining the
functional importance of a given modification is site occu-
pancy [26]. Again, only rarely and at the expense of additional
analytical steps has this been addressed [27,28]. Finally,
few methods exist that target multiple cysteine oxoforms.
Attempts have been made to target the SNO and a pool of all
reversibly oxidised cysteines in parallel [29]. However, further
development of such strategies targeting individual modifi-
cations simultaneously is important to decode potential
cross-talk between different cysteine oxoforms.
In addition to the limitations of existing methods the
majority of studies investigating cysteine oxidative modifica-
tions use in vitro models where oxidation is induced chemi-
cally, for example by treatment with S-nitrosoglutathione
(GSNO) [30,31]. Such models do not reflect physiological
levels of oxidative modifications. Additionally, they are often
performed outside cellular environment and in denaturing
conditions, which neglects the role of protein structure in the
susceptibility of cysteine to oxidation.
Here we present an analytical strategy which provides
quantitative analysis of cysteine SNO and SOH simultaneously
including precise assignment of modification site. The method
inherently corrects for protein abundance changes and permits
determination of relative site occupancy of both modifications.
To achieve this we make use of Iodoacetyl Tandem Mass Tags
(iodoTMT™) which are a variant of the popular amine reactive
TMT™ isobaric labels. Replacement of the amine reactive group
with a thiol reactive iodoacetyl moiety allows for quantitative
analysis of cysteine subproteomes by tandem mass spectrom-
etry [32]. Enrichment or immunoassay based detection of
iodoTMT™-containing peptides and proteins is achieved by
the application of an anti-TMT™ antibody. As with their amine
counterpart, isobaric iodoTMT™ tags allow for concurrent
analysis of up to six samples [32]. In the presented configura-
tion, our SNO/SOH TMT method allows analysis of two
treatment groups in one experiment.
SNO/SOH TMT was developed and optimised to target near
physiological levels of oxidative stress and to characterise
proteins modified in native conditions. To test the applicabil-
ity of the method to analysis of complex biological samples
we have used SNO/SOH TMT strategy to analyse the thiol
redox proteome of E. coli under mild oxidative stress induced
in vivo. Our model was built upon previous works with minor
alterations [6]. Induction of SNO was achieved by anaerobic
growth in minimal media supplemented with nitrate, where-
as fumarate was used in the control group. SOH was induced
by brief in-culture stimulation with hydrogen peroxide (H2O2).
We show that the SNO/SOH TMT strategy provides robust
and reproducible method for identification of the modifica-
tion site and quantification of the relative abundance of SNO
and SOH in proteins. Combined with anti-TMT™ enrichment
it is sensitive enough to measure the endogenous levels of
thiol modifications. Our results indicate that SNO and SOH
coexist on several cysteine residues and only few of the
modified residues change between low and mild oxidative
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stress conditions. The approach presented expands out
tool-box for redox proteome analysis and opens up new
possibilities for studying the interdependence of different
cysteine oxoforms. We emphasise that although SNO/SOH
TMT is a powerful methodology for screening of SNO and SOH
alterations in response to changes in ROS/RNS levels, the
information it provides should be evaluated further with
alternative analytical strategies in order to reveal their true
biological importance.
2. Materials and methods
2.1. Materials
Anaerogen, iodoTMT™ tags, immobilised and unbound anti-
TMT™ antibody, Tris-buffered saline (TBS), tris(2-carboxyethyl)
phosphine (TCEP), TMT elution buffer, Pierce Screw Cup Spin
Columns Zeba Spin desalting columns and BCA assay were
from Thermo Scientific. The remaining chemicals were from
Sigma Aldrich unless stated otherwise. All solvents were of
analytical or higher grade.
2.2. Methods
For all reagents, final concentrations are reported, unless
started otherwise. All steps from oxidation induction to
quenching after iodoTMT™ labelling were performed under
minimal light exposure.
2.2.1. Cultivation of E. coli, in vivo oxidation
A single colony of E. coli K-12 was inoculated from LB agar
plate to 10 ml LB liquid medium for overnight growth at 37 °C
with shaking. Overnight cultures were recovered by centrifu-
gation and washed in MOPS minimal media once before
making a 4% (v/v) inoculation into 50 ml MOPS minimal
media [33] supplemented with 100 mM disodium fumarate
(control, n = 3 independent biological replicates) or 100 mM
sodium nitrate (stressed, n = 3). Flasks were transferred to
2.5 l anaerobic jars together with AnaeroGen and Anaerotest®
(Merck, Millipore). Bacteria were grown in the dark for 7 h at
37 °C with gentle agitation. 100 μM H2O2 was added to the
stressed group 5 min prior to cell harvest. Cells were collected
by centrifugation (4500 ×g, 20 min, 4 °C) and washed twice
with ice cold phosphate buffered saline (PBS), pH 7.4. Finally
cell pellets were resuspended in lysis/blocking buffer contain-
ing 150 mM HEPES, pH 7.3, 1 mM EDTA, 0.1 mM neocuproine,
2% SDS, 50 mMMMTS (S-Methyl methanethiosulfonate). Cells
obtained from 50 ml of cultures at OD600 = 0.7 were lysed in
4 ml of lysis/blocking buffer by applying 5 rounds of 10 s
on/off sonication cycles at an amplitude of 25% in a tip sonicator
(Q500, Qsonica). Cell lysates were incubated for 30 min at
room temperature (RT) with gentle agitation, precipitated with
10 volumes of ice cold acetone for 1 h at −20 °C and centrifuged
(4500 ×g, 20 min, 4 °C). Protein pellets were washed twice with
ice cold acetone, using a tip probe sonicator to disrupt the pellets
between washes. Washed pellets were resuspended in AENS
buffer (50 mM ammonium bicarbonate, pH 8.0, 1 mM EDTA,
0.1 mM neocuproine, 2% SDS). Protein concentration was
measured using BCA assay.
2.2.2 . iodoTMT™-6plex labelling
IodoTMT™ 6plex reagents were used in reductive alkylation of
both control and stressed samples. For total cysteine labelling,
100 μg of protein extracts (1 μg/μl) was reduced with 10 mM
TCEP in AENS buffer for 1 h at 56 °C. TCEP was then removed
using Zeba Spin desalting columns exchanging buffer for
AENS buffer without TCEP, following the manufacturer's
instructions. Reduced samples were alkylated with 5 mM
iodoTMT™-126 (control) and iodoTMT™-127 (stressed). For
SNO, 1 mg of each sample (2 μg/μl) was reduced with 20 mM
sodium ascorbate and alkylated with 0.9 mM iodoTMT™-128
(control) and iodoTMT™-129 (stressed). For SOH, 1 mg of each
sample (2 μg/μl) was reduced with 10 mM sodium (meta)
arsenite and alkylated with 0.9 mM iodoTMT™-130 (control),
iodoTMT™-131 (stressed). For all the samples, iodoTMT™
labelling was carried out for 2 h at 37 °C with shaking.
Reactions were quenched by adding 500 mM dithiothreitol
(DTT) and 15 min incubation. An aliquot of each sample (4 μg)
was saved for western blot analysis before combining all
samples. Samples were pooled using the following scheme:
1:10:10 of total cysteines:SNO:SOH and precipitated with
10 volumes of ice cold acetone overnight at −20 °C. Pellets
were washed three times with ice cold acetone/methanol
(50% v/v) to remove excess iodoTMT™ reagents.
2.2.3. Reduction, alkylation, enzymatic digestion and peptide
desalting
Final protein pellets were resuspended in digestion buffer
(50 mM ammonium bicarbonate, pH 8.0, 8 M urea). Samples
were reduced with 20 mM DTT for 45 min at RT and alkylated
with 55 mM iodoacetamide (IAA) for 30 min at RT in the dark.
Proteins were digested with lysyl endopeptidase (Wako Pure
Chemical Industries, Ltd.) for 3 h at 30 °C with shaking. Next,
samples were diluted with 50 mM ammonium bicarbonate to
reduce urea concentration below 2 M, before trypsin was
added (1:50, enzyme to protein ratio) for overnight digestion at
37 °C with shaking.
Peptide solution after digestion was acidified with
trifluoroacetic acid (TFA, 0.5%) and desalted using HLB
cartridge (Oasis, Waters). Briefly, HLB cartridge was washed
with methanol, acetonitrile (ACN) and 80% ACN, 0.1% TFA
(1 ml each) and equilibrated with 0.1% TFA (3 × 1 ml). Peptides
were loaded on the cartridge 5 times. Washing was 0.1% TFA
(5 × 1 ml) followed by elution of bound peptides with 80%
ACN, 0.1% TFA (1 ml). Eluates were vacuum dried and
resuspended in Tris-buffered saline (TBS), pH 7.0. A small
aliquot was taken for amino acid analysis on a Biochrom 30
(Biochrom Ltd., UK) to determine peptide quantities prior to
anti-TMT™ enrichment.
2.2.4. Anti-TMT™ enrichment and sample clean-up
Approximately 2 mg of the iodoTMT™ 6plex sample was
enriched on anti-TMT™ columns. The amount of anti-TMT™
resin was calculated from the following equation: resin slurry
[μl] = 142.858 x sample amount [mg]. Samples were incubated
with anti-TMT™ resin in Pierce Screw Cap Spin Columns
for 2 h at RT with end-over-end shaking. For all subsequent
steps, resin was incubated with each solution for 10 min as
described above. Washes were: 2 M urea in TBS (2 column
volumes) followed by 0.1% SDC in TBS and TBS only (3 column
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volumes each). iodoTMT™-containing peptides were eluted
from the resin with 4 column volumes of TMT elution buffer.
Eluate fractions were acidified with TFA (0.5%), centrifuged to
pellet any residual SDC (20 000 ×g, 5 min, RT), removed to a
fresh tube and vacuum dried. Samples after anti-TMT™
enrichment were desalted on in-house made micro-columns
packed with reverse phase material POROS 20R2/R3 as
previously described [34,35].
2.2.5. HILIC fractionation
Portions of iodoTMT™-6plex labelled samples (20 μg) were
fractionated by hydrophilic interaction chromatography
(HILIC) using off-line Agilent 1200 HPLC equipped with
automatic fraction collector. Samples were separated on
in-house made HILIC microcolumn (320 μm ID × 15 cm
packed with TSKgel Amide 80 resin (Tosoh Bioscience)) at a
flow rate of 6 μl/min, in linear, 8 min gradient from 95 to 60%
B. Solvent A was 0.1% TFA, solvent B was 90% ACN, 0.1% TFA.
Eluted peptides were automatically collected at 1 min frac-
tions into a 96 well plate.
2.2.6. nLC-MSMS data acquisition
nLC-MSMS data were acquired on a Dionex UltiMate™ 3000
Rapid Separation UHPLC interfaced via an EASY-Spray™ nano
electrospray source to Q-Exactive™ Plus mass spectrometer
(Thermo Scientific). The trapping column was 100 μm ID,
2 cm long, packed with 5 μm Reverse Phase C18 material
(Reprosil, Dr Maisch, Germany). Analytical column was a
Thermo Scientific EASY-Spray™ column of 75 μm ID, 50 cm
long, packed with 2 μm C18 particles. Loading solvent was
0.1% TFA, analytical solvents A and B were 0.1% formic acid
(FA) and 0.1% FA in ACN. All separations were carried out at
40 °C. Samples were resuspended in 1% TFA, 5% DMSO and
loaded onto the trap column at 10 μl/min for 5 min. Peptides
were eluted onto and separated over the analytical column
with the linear gradient of solvent B (2–35%) for 90 min. 2.1 kV
voltage was applied for electrospray. The quadrupole isolation
width was set to 2 m/z. MS1 scans in the m/z range 300–1200
were acquired in the Orbitrap with 70 000 resolution at an
AGC target of 1E6 and maximum injection time of 120 ms.
AGC target and maximum injection time for MS2 were 2E4
and 60 ms, respectively. Tandem mass spectra were acquired
in data-dependent manner with top 12 most intense ions
per MS1 scan selected for fragmentation at a threshold of
10 000 counts. Dynamic exclusion was set to 45 s. Normalised
collision energy (NCE) was 34 and fragment ions were
detected from 110 m/z at 17 500 resolution.
2.2.7. Database search
MS data were searched against the Uniprot Reference E. coli
proteome (4303 entries, July 13th 2012) with common con-
taminants from GPM appended [36] using in-house Mascot
server from within Proteome Discoverer version 1.4. The
following search parameters were used: enzyme — trypsin, 2
missed cleavages, precursor mass tolerance — 10 ppm and
fragment mass tolerance — 20 mmu; variable modifications
were — iodoTMT™ (Cys), carbamidomethylation (Cys) and
oxidation (Met). Mascot Percolator was used to estimate
Peptide-Spectrum Match False Discovery Rate and only
peptides with a percolator q-score ≤ 0.01 were taken forward
for analysis. The reporter ion quantifier node of Proteome
Discoverer set to a 20 mmu tolerance, using themost confident
centroid was applied to extract reporter ion intensities for TMT
quantification. Default protein grouping options were applied.
2.2.8. Normalisation and significance analysis
Ratios of respective reporter ion intensities (127/126, 129/128
and 131/130) were log(2) transformed and normalised to the
median value. Normalised ratios for SNO (129/128) and SOH
(131/130) were corrected for the respective total cysteine ratios
(127/126). The significance threshold — two times standard
deviation (2 sigma) was then calculated for each of the
normalised and corrected ratios of modifications. Peptides
with log(2) ratios ±2 sigma were considered of highest
biological significance.
2.2.9. Label-free quantitative proteomics
E. coliwere grown anaerobically as described above. Cells were
collected by centrifugation (4500 ×g, 20 min, 4 °C) and washed
twice with ice cold PBS. Final cell pellets were resuspended in
lysis buffer (20 mM Triethylammonium bicarbonate (TEAB)
pH 8.0, 2% SDS) and lysed as above. Protein concentration was
determined by BCA assay. Samples were digested on-filter
with MS-compatible detergent sodium deoxycholate (SDC)
[37]. Briefly, protein samples were loaded onto ultrafiltration
devices (30 kDa Vivacon, Vivaproducts, Inc.) and washed first
with urea to remove SDS and then with SDC to remove urea
and provide a denaturing environment for digestion. Reduc-
tion (DTT) and alkylation (IAA) were performed on-filter prior
to digestion with trypsin as described before [37]. Peptides
were recovered by centrifugation and SDC was removed by
precipitation with TFA and phase transfer into ethyl acetate
as described before [38].
nLC-MSMS analysis and database search were performed
essentially as above, with few exceptions. For MS2, NCE was
28 and fragment ions were detected relative to the precursor's
m/z. In database search, cysteine carbamidomethylation was
used as fixed and methionine oxidation as variable modifica-
tion. Quantitative information from label-free experiments was
retrieved from nLC-MSMS data using chromatographic align-
ment feature within Progenesis LC-MS (Nonlinear Dynamics).
Automatic reference selection, run alignment and peak picking
were used to align all acquired spectra. Search results from
ProteomeDiscovererwere imported to identify aligned features.
Significance analysis was performed using the built in ANOVA
test. Proteins with at least 2 quantified peptides and ANOVA
significance value p ≤ 0.05 were considered significant.
2.2.10. In vitro oxidation and western blot analysis
A single colony of E. coli was inoculated from an LB agar
plate into 20 ml LB liquid media and grown overnight to
stationary phase before harvesting by centrifugation. Cell
pellets were resuspended in HES buffer (150 mMHEPES, 1 mM
EDTA, 2% SDS) and lysed by sonication as described above.
Protein concentration was measured by BCA assay. 4 mg of
protein lysate was used for in vitro oxidation and subsequent
analysis. A schematic outline of the experiment is presented
in Fig. S1.
S-nitrosoglutathione (GSNO) was used to induce SNO
(200 μM GSNO for 30 min at RT). To induce SOH, protein
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lysates were treated with 100 μM hydrogen peroxide for
15 min at 37 °C. Oxidised samples were immediately precip-
itated with 10 volumes of ice cold acetone, for 1 h at −20 °C.
Protein pellets were washed twice with acetone and resus-
pended in lysis/blocking buffer. All steps from free thiol
blocking until quenching after iodoTMT™ labelling were
essentially as described above, with minor changes. 25 μg of
protein lysate (2 μg/μl in AENS buffer) was used for labelling
with iodoTMT™-zero. In addition to SNO and SOH analysis,
MMTS blocking efficiency was tested. Here samples were
directly incubated with 0.9 mM iodoTMT™-zero. All labelled
and quenched samples were denatured in Bolt® LDS Sample
Buffer with 50 mM DTT for 10 min at 70 °C. For SDS-PAGE
Novex®Bolt® (Life Technologies) gel electrophoresis system
was used following the manufacturer's instructions. 4 μg of
each sample was loaded on a gel and separated in NuPAGE®
MES SDS Running Buffer for 35 min at 165 V. Proteins
were electrotransferred from gel onto a PVDF membrane
(Immobilon®-P, 45 μm pore size, Merck Millipore) in cold
Towbin buffer for 20 min at 18 V using semidry-western blot
system (Trans-Blot® SD, Semi-Dry Transfer Cell, Bio-Rad).
Membranes were incubated in blocking buffer (5% non-fat
milk powder in TBS with 0.1% (v/v) Tween 20 — TBST)
overnight at 4 °C with shaking. Primary antibody (anti-TMT
™ antibody; 1:5000 in blocking buffer) incubation was 1 h at
RT with shaking, followed by 3 × 10 min washes in TBST.
Secondary antibody (Anti-mouse IgG2b from Rabbit Peroxi-
dase Conjugated, Rockland Immunochemicals; 1:10 000) in-
cubation was 1 h at RT with shaking, followed by 3 × 10 min
washes in TBST. For development peroxidase substrate
(Luminata™ Forte, Merck Millipore) was incubated for 2 min.
The chemiluminescent signal was captured using BioSpectrum®
2D Imaging System (Ultra-Violet Products Ltd). Density analysis
was performed using Image StudioTM Lite version 3.1 (LI-COR®
Biosciences) as previously described [39].
3. Results
3.1. SNO/SOH TMT — method for simultaneous analysis of
SNO and SOH
We have developed and tested a proteomics-based strategy
for simultaneous detection and quantitation of two reversible
cysteinemodifications, SNOand SOH. The basic principles of the
strategy are presented in Fig. 1. SNO/SOH TMT strategy is based
on alkylation with Iodoacetyl Tandem Mass Tags (iodoTMT™
tags) for labelling of reduced cysteines (SH) and TMT specific
antibody for enrichment of iodoTMT™ labelled peptides.
The method consists of five components: 1) cell lysis and
reversible blocking of free SH groups with MMTS; 2) differential
reduction of “total” cysteines, S-nitrosylated cysteines and
S-sulfenylated cysteines with TCEP, sodium ascorbate and
sodiumarsenite respectively followed by iodoTMT™ alkylation;
“total” cysteines refers to all cysteines that are/can be reduced
to sulfhydryl groups, this includes free cysteines and all
DTT/TCEP reducible cysteinemodifications including disulfides
(S-S), SNO and SOH 3) reduction and alkylation of pooled
samples followed by proteolytic digestion; 4) enrichment of
iodoTMT™-containing peptides using TMT specific antibody;
and 5) analysis of peptide fractions by nano liquid chromatog-
raphy coupled to tandemmass spectrometry (nLC-MSMS). The
experimental conditions used in this study have been adapted
from the iodoTMT™ supplier instructions [40] and tested for
suitability in the described workflow. Table 1 and Fig. S2
summarise the different steps of the method.
3.1.1. Blocking of free thiols
Free thiol blocking is critical. Any failure at this step will
artifactually increase the final cysteine oxidation readouts.
For the E. coli protein extracts used in this study we have
determined that 4 ml of lysis/blocking buffer was sufficient to
block sulfhydryl groups from ~3.5 × 1010 E. coli cells obtained
from 50 ml culture at OD600 of 0.7. The final concentration of
MMTS was 50 mM, which roughly corresponds to 33 nmol
MMTS per 1 μg protein. The efficiency of MMTS blocking was
assessed by western blot analysis (Fig. 2A and Fig. S3A).
Additionally we have observed that simultaneous cell lysis
and MMTS blocking as opposed to sequential cell lysis and
MMTS blocking gave the most complete and reproducible
results (data not shown). Despite extensive optimisation,
MMTS blocking was not complete and a low background
signal was detected (Fig. S3A).
3.1.2. Selectivity of modification specific reductions
The concept of SNO/SOH TMT is built upon the selectivity of
modification specific reductions. Based on the current litera-
ture we have chosen 20 mM ascorbate and 10 mM arsenite for
selective reduction of SNO and SOH respectively [29,41].
Western blot analysis was used to test the efficiency of
modification specific reductions, the outline of the experi-
ment is presented in Fig. S1. For testing the specificity of
reductions, SNO and SOH were induced in vitro, by direct
treatment of E. coli lysates with GSNO and H2O2 respectively.
Each fraction was alkylated with iodoTMT™ reagent either
directly (H2O) to test efficiency of free thiol blocking with
MMTS or after ascorbate or arsenite reduction. The level of
iodoTMT™ label incorporation into proteins was detected by
anti-TMT™ antibody. The results are shown in Fig. 2A. As
expected, the non-oxidised proteins (control) have shown
an equal, relatively low signal in all reduction conditions.
Proteins treated with GSNO have shown a similar low signal
level for non-reduced samples (H2O) and samples reduced
with arsenite. These low levels of unspecific iodoTMT™
labelling are most likely due to incomplete blocking of free
sulfhydryls with MMTS. At the same time samples treated
with ascorbate, which specifically reduces SNO, have shown a
5 fold signal increase, confirming the efficient iodoTMT™
labelling of SNO modified cysteines. Proteins treated with
H2O2 have shown a similar pattern of increased signal
observed in arsenite reduced samples as compared to the
control. Interestingly H2O2 treated samples that were subse-
quently reduced with ascorbate have shown a similar level of
iodoTMT™ label incorporation as those reduced with arsenite
indicating the presence of SNO groups. Under these particular
oxidative conditions not only SOH but also SNO was
increased. Although H2O2 was not known to induce SNO
directly, elevated SNO levels in the presence of H2O2
have been reported previously [42]. Additionally, a recent
study by Hlaing et al. clearly documents increased protein
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S-nitrosylation as a direct response to H2O2 treatment in
serum starved mouse embryonic fibroblasts [43]. H2O2 may
also mimic and complement the effects of nitric oxide as it
has been reported for human platelets [44]. The chemistry
behind such interplay remains unsolved [45]. Both modifica-
tion specific reductions resulted in a higher signal than the
negative control and a much lower signal than in the fully
reduced control (Fig. 2A and Fig. S4).
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3.1.3. Multiplexing
The stoichiometry of SNO/SOH modified cysteines compared
to the number of total cysteines is low. This is important
when considering the labelling chemistry and in which ratio
labelled protein is mixed. TCEP reduced protein has a high
number of potential sites at which iodoTMT™ may be
incorporated. Therefore it requires a relatively higher amount
of iodoTMT™ label per amount of protein than for ascorbate
(SNO) and arsenite (SOH) reductions. Additionally, to main-
tain a balance between reporter ion intensities less protein
from TCEP reduction (total cysteine labelling) should be used
than for either ascorbate or arsenite reduction. Based on
western blot and mass spectrometry analysis we have
determined that 10 times less protein for total cysteine
(TCEP reduced) compared to modified (ascorbate or arsenite
reduced) was appropriate (Fig. 2B and Fig. S4).
3.1.4. Enrichment of TMT labelled peptides
In the presented approach we have followed the recommenda-
tions provided by the iodoTMT™ supplier [40]. This included a
wash step with sodium deoxycholate where washing with a
“mass spectrometry compatible detergent”was recommended.
The selectivity of the enrichment obtained ranged from 50% in
samples containing high levels of iodoTMT™ labelled peptides
(e.g.where iodoTMT™ labelling was achieved by reduction and
alkylation of total cysteines or chemical induction of SNO/SOH)
to 7% for samples where the levels of SNO and SOH were
endogenous (induced by growth on nitrate and H2O2 stress).
We hypothesised that peptide pre-fractionation could re-
place anti-TMT™ enrichment when dealing with a low amount
of startingmaterial. We have compared hydrophilic interaction
chromatography (HILIC) based fractionation of a low amount of
starting material (20 μg) with anti-TMT™ enrichment of a high
amount of starting material (2 mg). The experimental outline
is presented in Fig. 3A. Using HILIC fractionation, we have
identified 254 unique, iodoTMT™-containing peptides (n = 3
independent biological replicates, Table S1). Anti-TMT™
enrichment resulted in total of 481 unique, iodoTMT™ peptides
(n = 3). The overlap between the two techniques was 23%,
corresponding to 139 peptides (Fig. 3B). In order to evaluate the
benefits of the enrichment strategy we have estimated the
precursor areas based abundance of iodoTMT™-containing
peptides identified by both methods (Fig. 3C). The results show
that the abundance of iodoTMT™ containing peptides from
HILIC fractionation is only 40%of respective peptides quantified
by iodoTMT™ enrichment approach.
Next we sought to investigate the quantitative precision of
the results obtained by the two approaches. We have plotted
the log(2) ratios of SNO/SOH peptides found in both iodoTMT™
enriched and HILIC pre-fractionated samples. The average
correlation from all 3 biological replicates was R2 = 0.749, ±0.16
for total cysteines, R2 = 0.361, ±0.16 for SNO and R2 = 0.204,
±0.09 for SOH (Fig. S5). Despite the good correlation between
quantitative information on total cysteines, the correlation
between modifications is poor. This can be traced back to very
low reporter ion intensities in the HILIC pre-fractionated
samples, which were on average an order of magnitude lower,
relative to anti-TMT™ enrichment (see Tables in Fig. S5). As
the total cysteine reporter ions are generally more intense than
for themodifications, this intensity reductionwasnot sufficient
to compromise quantitative precision. However, in the case
of SNO and SOH, the reporter ion intensities are low in the
enriched samples and therefore even lower in the HILIC
samples. This resulted in diminished quantitative precision.
3.2. Anaerobic growth on nitrate or fumarate induces
alterations in protein abundance and oxidation levels
The presented analytical strategy was tested on E. coli extracts
where endogenous proteins SNO and SOH were induced. This
was achieved by following a previously published protocol
with few alterations [6]. Briefly, to obtain low oxidative growth
conditions E. coliwere cultured anaerobically using fumarate as
a terminal electron acceptor. These conditions were compared
to E. coli cells grown in the presence of nitrate, which was
expected to induce accumulation of S-nitrosylated proteins.
Finally, SOH was induced by addition of H2O2 to the nitrate
culture.
Table 1 – Optimised conditions for SNO/SOH TMT strategy for simultaneous identification and quantitation of 3 distinctive
cysteine subsets.
Step Final conditions used
Cell lysis and free thiol blocking Blocking of free SH groups 50 mM MMTSa in lysis buffer
Removal of MMTS excess Acetone precipitation for 1 h at −20 °C
Differential reduction and alkylation Total cysteine reduction Sequential reduction (10 mM TCEP) and alkylation (5 mM iodoTMT™)
SNO reduction 20 mM ascorbate (0.9 mM iodoTMT™)
SOH reduction 10 mM arsenite (0.9 mM iodoTMT™)
iodoTMT™ labelling 2 h at 37 °C
Quenching excess iodoTMT™ 500 mM DTT for 15 min at 37 °C
Multiplexing Mixing ratio 1 (total):10 (SNO/SOH)
Peptide quantitation Amino acid analysis
Anti-TMT™ enrichment Amount of anti-TMT™ resin slurry 200 μl b
Incubation 2 h at RT (24 ± 1 °C)
Washing Sequential: urea, SDC, TBSc
Elution TMT elution bufferd
a All values refer to final concentrations of chemicals during reaction.
b For both total and SNO/SOH labelling resin amount was calculated based on manufacturer's recommendations.
c Washing buffers were: 2 M urea in TBS, 0.1% SDC in TBS and TBS only.
d When using TMT elution buffer triethylammonium (TEA)-containing buffers should be avoided throughout the procedure.
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To confirm that cellular metabolism was switched to
anaerobic respiration using fumarate or nitrate as the terminal
electron acceptor we performed label-free quantitative mass
spectrometry of control (fumarate growth) and stressed (nitrate
growth) samples. In total we have quantified 1581 proteins.
From these, 669 proteins were significantly (p ≤ 0.05) regulated
between nitrate and fumarate grown bacteria (Table S2). The
majority of the components of the dissimilatory nitrate
reduction pathway were significantly increased in abundance
in nitrate grown cells and fumarate reductase was increased in
abundance in fumarate culture (Fig. 4). These data confirm that
an anaerobic atmosphere was generated and resulted in a
metabolic shift to fumarate or nitrate reduction, depending on
the culture conditions.
Label-free quantitative proteomics results were compared to
the results obtained from total cysteine labelling, where the
samples were treated with TCEP, to reduce reversibly modified
cysteines, and labelled with iodoTMT™ tags. The aim was to
confirm that changes in protein levelsmeasured by quantitation
of cysteine-containing peptides will reflect the endogenous
changes in protein abundance levels measured using the
label-free approach. Comparison of the data obtained by the
two approaches in 3 biological replicates showed a high
correlation of R2 = 0.752 ± 0.08 (Fig. 5) supporting the applicabil-
ity of total cysteine labelling for correction of protein abundance
changes. Additionally these results further demonstrate that
both iodoalkylation chemistry and iodoTMT™-based relative
quantitation is robust in a simple system (total cysteines). Thus,
we consider this chemistry to be applicable to the study of
reversible cysteine modifications e.g. SOH.
In order to obtain estimates of global SNO/SOH levels in the
analysed samples we have performed western blot analysis.
This analysis provided an indication for the direction of
SNO/SOH changes. The results show a clear increase in
protein SNO induced by growth on nitrate as compared to
fumarate (Fig. 2B and S3A). SOH although less pronounced
was also induced. As anticipated, the total SNO and SOH
levels were much lower than those obtained by in vitro
oxidation induced by GSNO and H2O2 (Fig. 2A). These data
are in line with the previously published work [6].
3.3. Redox proteome of E. coli grown anaerobically on nitrate
or fumarate
The described SNO/SOH TMT strategy was applied to the E. coli
model of mild oxidative stress. All unique, SNO/SOH
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Fig. 2 – Induction of SNO and SOH in E. coli proteins. A. In vitro by treatment with GSNO (200 μM) or H2O2 (100 μM); B. in vivo by
anaerobic growth on nitrate and in-culture stimulation with H2O2 (100 μM); SNO and SOH were detected by western blot using
anti-TMT™ antibody (upper panels), densitometry analysis (n = 3) (lower panels). F — fumarate, N— nitrate.
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containing peptides identified in all 3 biological replicates are
listed together with their features in Table S3. In total we
identified 480 unique peptides and 540 cysteine sites contain-
ing SNO, SOH or both modifications (Fig. 6A). Almost 66% of
modified proteins were foundwith single cysteine SNO and/or
SOH site (Fig. 6B). There were also 108 proteins containing
multiple modification sites. Glutamate synthase [NADPH]
large chain (P09831, GltB) was found with 8 oxidised cysteines.
We have compared the identified proteins/sites to RedoxDB,
currently the largest repository of experimental evidence for
cysteine oxidative modifications [46]. From the 83 oxidatively
modified proteins identified in this study only 16 are reported
in RedoxDB. These 16 proteins cover 19 cysteine oxidation
sites from which 7 match the site localisation from RedoxDB.
Interestingly, for 4 of the matched sites, the modification type
was not previously determined (Table S3).
In this work, quantitative results measuring levels of SNO
and SOH modifications were only considered if the same
peptide was found in the 3 biological replicates analysed
(114 unique peptides). For 105 of those peptides (111 sites) SNO
and SOH levels were quantified simultaneously. Additionally 8
peptides (from 8 proteins) contained only SNO. There were no
peptides which exclusively contained iodoTMT™ reporter ions
representing SOH modification. The 113 peptides containing
both SNO/SOH and SNO only correspond to 90 proteins. The
majority of these proteins are localised to the cytoplasm (37)
several to membrane (8) and periplasm (3), many (42) were of
unknown localization according to ontological information
present in the Uniprot database (Fig. 6C). Network analysis
using STRING (version 9.1) shows that the modified proteins
cover several basic molecular pathways present in E. coli such
as the Krebs cycle (p = 3.2 × 10-2, n = 6); alanine, aspartate
and glutamate metabolism (p = 1.1 × 10-2, n = 7) and nitrogen
metabolism (p = 2.4 × 10-2, n = 7) (Fig. 7).
3.3.1. Changes in SNO and SOH levels between low and mild
oxidative stress
In order to evaluate the significance of the observed quanti-
tative differences between low and mild oxidative stress we
have used a 2 sigma approach. Results were log(2) trans-
formed and normalised to the median. Normalised ratios
for SNO and SOH were corrected for changes in protein
abundance according to the ratio observed for total cysteine
measurement.
In order to identify proteins with significant changes in
SNO or SOH modification we adopted a two tier selection
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criteria. The stringent criteria required that modified peptides
were above 2 sigma fold change in SNO or SOH level in all 3
biological replicates. The relaxed criteria required 2 sigma fold
change in 2 replicates.
Interestingly more than 80% of the quantified peptides
showed no significant change in modification levels between
the two experimental conditions. This may result from a
moderate quantitation precision obtained in these experiments
(Fig. S6). The quantitation precision for total cysteines was very
high (average R2 = 0.769 ± 0.01), for SNO peptides was slightly
lower (average R2 = 0.529 ± 0.02) and the largest inter-replicate
variance was observed for SOH (average R2 = 0.200, ±0.06). As
discussed above, the quantitative precision is related to the
reporter ion intensity which is linked to the abundance of the
modifications in the sample. These data indicate that labelling
more protein for SOH analysis would improve quantitative
precision.
Despite this limitation, applying strict selection criteria, 6
of 105 peptides were found in altered abundance between
fumarate and nitrate growth. These peptides belong to 3
proteins. Respiratory nitrate reductase 1 beta chain (P11349,
NarH), fumarate reductase flavoprotein subunit (P00363, FrdA)
and aldehyde–alcohol dehydrogenase (P0A9Q7, AdhE). Apply-
ing relaxed selection criteria revealed 10 more peptides which
were quantified in at least 2 of the biological replicates.
Among these, 2 were from fumarate reductase flavoprotein
subunit and aldehyde–alcohol dehydrogenase with one addi-
tional peptide for each protein respectively. The remaining 8
peptides were from 8 distinct proteins. Table 2 lists the most
differentially oxidised proteins together with modification
fold change and relative site occupancy data. Fig. S7 provides
annotated MSMS spectra of the modified peptides.
3.4. Relative modification site occupancy
A unique feature of SNO/SOH TMT approach is the ability of
simultaneous quantification of peptides containing 3 cysteine
forms: fully reduced, SNO and SOHmodified. This allows us to
calculate relative modification site occupancy. It is calculated
as a percentage of reporter ion intensities from SNO and SOH
cysteines, compared to total cysteines. It is important to stress
that due to undetermined efficiency of ascorbate and arsenite
reduction these site occupancy levels should only be considered
as relative and not absolute values, therefore we refer to them
as relative modification site occupancy. Results of SNO/SOH
occupancy analysis are presented in Table 2 and Supplementary
Table S3.
From this analysis we calculated the average site occu-
pancy for each modification. These numbers should reflect
the global levels of SNO or SOH in the analysed samples. The
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baseline level of SNO occupancy in fumarate growth was
3% increasing to 4.5% under nitrate growth. SOH exhibited
approximately 1.1% occupancy under fumarate growth, in-
creasing to 1.3% in stress conditions.
The relative occupancy of individual sites was also
investigated. The residue with the largest percentage of SNO
occupancy in nitrate grown E. coli was C184 of NarH with
21.2% ± 4.6 of residue modified. Interestingly this residue also
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Fig. 5 – Correlation of protein abundance changes between label-free and total cysteines iodoTMT™ labelling approaches.
Correlation coefficient (R2) was calculated for each pair of respective replicates. Accordingly, A–C corresponds to replicates 1–3.
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exhibits the largest SOH occupancy 7.8% ± 4.3 (Fig. 8A).
Respiratory nitrate reductase was also found to be among
the most differentially oxidised proteins (see Table 2). The
protein with the second highest relative site occupancy
observed was NADP-specific glutamate dehydrogenase
(P00370, GdhA). Its residue C147 was 12% ± 1.3 S-nitrosylated
under nitrate growth (Fig. 8B). Interestingly neither the
abundance of this protein nor its modification changed
under mild oxidative stress. The third protein with largest
SNO site occupancy was PTS-dependent dihydroxyacetone
kinase, phosphotransferase subunit DhaM (P37349, DhaM).
Here 10.5% ± 0.7 of C195 was modified under nitrate growth
(Fig. 8C).
The second largest relative site occupancy by SOH was
Protein YeeZ (P0AD12, YeeZ). Its residue C213 was 3.2% ± 0.7
S-sulfenylated in nitrate (Fig. 8D). Cysteine C45 of Ketol-
acid reductoisomerase (P05793, IlvC) was the third most
S-sulfenylated residue. Although the actual site occupancy
was rather low 2.9% ± 0.4 (Fig. 8E). The examples of NarH and
GdhA show that high occupancy does not necessarily imply
that a particular site is differentially modified under stress.
The fact that both relative abundance and relative site
occupancy can be derived from a single experiment is
therefore a considerable advantage of the SNO/SOH TMT
method.
4. Discussion
4.1. SNO/SOH TMT strategy
Differential alkylation is a common strategy in studies of
cysteine oxidation [2]. It is also the basis of the current work.
Here we use iodoTMT™ providing a permanent mass tag that
can be enriched and detected bymass spectrometry. Although
isobaric iodoTMT™ tags allow for sample multiplexing [32] our
strategy favours multifunctionality. We use isobaric iodoTMT™
tags for simultaneousanalysis of 3 distinctive cysteine subsets in
2 experimental conditions. Our targets are total (TCEP reduced),
S-nitrosylated and S-sulfenylated cysteines. The notable fea-
tures of this approach are: 1) direct identification of modified
cysteine; 2) correction of changes in protein modification
levels by changes in protein abundance in a single experiment;
3) estimation of relative modification site occupancy; 4) simul-
taneous analysis of two different types of cysteinemodification.
4.1.1. Identification of modified cysteines
In common with some other methods, our SNO/SOH TMT
approach provides resolution of the site of modification
[15,16,32]. This is of critical importance as it allows one to
demonstrate if modifications are occurring in functionally
important regions of a protein. For example, we identified
several sites which coordinate iron–sulfur clusters and one
example (AdhE) of an active site cysteine (discussed in more
detail below).
4.1.2. Correction of changes in protein modification level by
changes in protein abundance level in a single experiment
We have used the multiplexing capability of the iodoTMT™
labels to include a control where all TCEP reducible cysteines
are derivatised. This allows correction of changes in protein
modification levels by changes in protein abundance levels in
a single experiment. Such correction is mandatory to depict
true modification levels and rule out all alterations caused
solely by changes in protein abundance levels, especially for
studies where long-term treatment is applied. Such correction
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has however rarely been implemented into previous thiol
redox strategies, as reviewed in [2]. Most of the strategies
attempting correction of modification levels by protein
abundance changes rely on non-isobaric isotopic labelling
which suffers from reduced sensitivity and multiplexing
capability [23–25]. Furthermore, most of these protocols are
laborious, requiring additional experiments employing alter-
native quantitation strategies and extensive fractionation to
determine protein abundance changes [23,25]. We overcome
these limitations in SNO/SOH TMT by using isobaric labels for
relative quantitation. Despite the known issues with dynamic
range compression due to precursor co-isolation in quantita-
tion with isobaric tags [47], we achieved an excellent
correlation of approx. 75% with label-free data. The slight
discrepancies between the label-free and iodoTMT™ total
cysteine labelling may originate from the contribution of
other reversible and irreversible cysteine oxoforms, sulfinic
and sulfonic acid. We recommend correcting SNO/SOH levels
by protein abundance changes determined by total cysteine
labelling as that should provide more accurate quantitation
then when using label-free data for correction, which do not
suffer from dynamic range compression.
4.1.3. Estimation of relative site occupancy
The quantitative information obtained from total cysteines
can also be used to estimate the fraction of the residue
occupied by the identified modification — relative
modification site occupancy. This information is believed to
have higher biological impact than the relative abundance
[28]. For instance modification site occupancy determines
level of enzyme inhibition and levels of protection against
irreversible oxidations [4]. It is especially important when
multiple PTMs are expected to occur at certain residue [26]
allowing the investigation of interplay betweenmodifications.
There have been previous studies attempting to determine
SNO site occupancy, one based on isobaric cysteine-reactive
TMT™ tags [28], the other based on phenylmercury enrich-
ment [27]. However, in these studies the contribution of
oxidative cysteine modifications (S–S, S–GS, SOH) was either
neglected [27] or required additional experimental steps to be
implemented [28]. In our strategy, not only SNO but also, for
the first time SOH site occupancy is measured as a percentage
of total cysteines, all retrieved from single nLC-MSMS
experiment. It should be noted that our SNO/SOH site
occupancy relies on MMTS blocking efficiency and ascorbate/
arsenite reduction specificity, which we did not fully assess.
However, these crucial steps have been thoroughly evaluated
by the others [6,48,49].
4.1.4. The ability to simultaneously analyse two different types
of cysteine modifications
Methodologies, such as the one recently published by Guo et
al. are powerful tools for studying cysteine redox proteomes
[49]. They allow for parallelized analysis of virtually any
Alanine, aspartate
and glutamate
metabolism Nitrogen 
metabolism
Pyruvate
metabolism
Krebs cycle
Glyoxylate and 
dicarbonate
metabolism
Cysteine
and 
methionine
metabolism
Ribosome
Fig. 7 – Interaction network of E. coli proteins modified (SNO/SOH) under mild oxidative stress. Continuous ovals— protein
groups significantly enriched in the dataset; Dashed ovals— other, functionally associated proteins. Network analysis was
performed using String version 9.1 with confidence view and confidence score of 0.700, no text mining was used.
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Table 2 – Proteins with the largest changes in SNO and/or SOH levels between nitrate (stressed) and fumarate (control) grown E. coli.
Protein name UniProt
acc.
Peptide sequence Modified
site(s)
Modification fold change log(2) between
fumarate and nitrate growtha, b
Relative site occupancy (%) c
SNO SOH SNO F SNO N SOH F SOH N
Aldehyde–alcohol dehydrogenase P0A9Q7 TFDNGVIcASEQSVVVVDSVYDAVR C246 1.798 1.719 1.164 1.373 1.301 0.408 1.6 6.8 0.8 1.6
LVAmGGIGHTScLYTDQDNQPAR C370 1.656 1.992 1.646 0.372 1.256 −0.346 0.8 4.0 0.8 1.2
LAPSLTLGcGSWGGNSISENVGPK C421 1.252 1.197 1.905 1.319 0.765 0.137 1.4 5.0 0.5 1.0
LSEDAFDDQcTGANPR C841 1.704 1.250 n/a 1.172 0.586 n/a 1.5 6.1 0.9 1.7
Fumarate reductase flavoprotein subunit P00363 GLFAVGEcSSVGLHGANR C381 1.497 1.508 1.612 1.091 1.561 1.189 1.8 7.6 0.7 1.9
IRDEmGLAmEEGcGIYR C464 1.280 1.174 1.682 0.447 0.540 0.202 1.4 5.4 1.0 1.7
EPIPVRPTAHYTmGGIETDQNcETR C368 1.868 1.654 n/a 1.206 1.959 n/a 0.9 4.3 0.5 1.7
Respiratory nitrate reductase 1 beta chain P11349 LcEHcLNPAcVATcPSGAIYK C184 0.146 0.217 −0.003 1.734 1.209 1.093 13.3 21.2 2.4 7.8
Acetolactate synthase isozyme 1 large
subunit
P08142 TDGKPAVcmAcSGPGATNLVTAIADAR C80, C83 −1.235 0.018 −2.299 −1.196 0.631 −2.667 3.4 1.5 0.5 0.2
Acetolactate synthase isozyme 1
small subunit
P0ADF8 NHPGVmTHVcGLFAR C26 n/a −1.065 −1.353 n/a −0.935 −1.205 5.2 3.6 1.7 0.9
Fumarate reductase iron–sulfur subunit P0AC47 mAIcGScGmmVNNVPK C63, C66 n/a 1.007 1.978 n/a 2.090 n/a 0.6 2.5 0.5 1.9
Nitrite reductase [NAD(P)H] large subunit P08201 SDAANFDITVFcEEPR C37 −0.890 −1.206 −0.992 −0.579 −1.027 −0.057 3.2 2.3 0.9 0.7
Peptidase T P29745 DcDIEPELKPIR C343 n/a 0.743 0.540 n/a 1.285 1.618 6.1 15.5 1.7 4.2
Probable dimethyl sulfoxide reductase
chain YnfF
P77783 cPEEHYVAFR C614 1.529 1.044 n/a 1.583 1.773 n/a 2.5 8.9 1.1 3.6
UPF0263 protein YciU P0A8L7 LcHIIWR C103 0.538 n/a −0.001 2.143 n/a 1.335 2.7 4.6 0.3 1.2
Bifunctional aspartokinase/homoserine
dehydrogenase 1
P00561 YVGNIDEDGVcR C755 0.701 1.481 n/a 1.726 0.757 n/a 0.4 1.0 0.1 0.2
n/a — not available.
a log(2) normalised and corrected by protein abundance change values.
b Significant modification change (≥2 sigma) are marked in bold; individual 2 sigma values were as follows SNO: 0.940, 0.956, and 0.991, SOH: 1.308, 1.054, and 1.081 for each replica respectively;
c % SNO/SOH site occupancy was calculated based on raw reporter ion intensities in relation to total cysteines from fumarate (F) or nitrate (N) grown E. coli.
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reversible cysteine modification. However, the unique de-
sign of SNO/SOH TMT approach provides, for the first
time, simultaneous detection and quantitation of two
distinct, reversible cysteine modifications, SNO and SOH.
As discussed below, this allows us to shed light on the
relationship between these two modifications and for the
first time investigate possible cross-talk between these
modifications.
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Fig. 8 – Modification site occupancy under nitrate growth. Peptides with the highest site occupancy for SNO (A–C) and SOH
(A, D–E) are presented.
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4.2. Optimisation of SNO/SOH TMT strategy
The fundamentals of SNO/SOH TMT strategy are based on
iodoTMT™ protocols provided by the manufacturers (Thermo
Scientific). However new elements have been added and
optimisation was performed to accommodate the novel features
of the method. The most critical optimisation work is discussed
below.
4.2.1. MMTS blocking of reduced sulfhydryl groups
Efficient blocking of free sulfhydryl groups (–SH) present in
protein extracts is a mandatory step to ensure no artifactual
increase in the observed cysteine oxidation levels. It can be
achieved by using MMTS [50,51], N-ethylmaleimide (NEM)
[24,52] or IAA [25] each with unique advantages and limitations
as reviewed in [53]. We have chosen to useMMTS because the
reaction pH is compatible with downstream sample process-
ing, which increases throughput of sample preparation and
minimises sample losses. Additionally, unlike NEM, MMTS
labelling is reversible and can be replaced with IAA prior to
trypsin digestion. This minimises the number of modifica-
tions that must be used for subsequent searches of
MS-derived data, reducing database search space and false
discovery rate. In our hands, the efficiency of free thiol
blocking was maximised when the blocking reaction was
performed directly during cell lysis. For E. coli a MMTS
concentration of 50 mM at a ratio of 33 nmol per 1 μg of
protein yielded, although not complete, however, relatively
effective blocking. The SNO/SOH TMT approach can be easily
combined with any blocking/alkylation reagent, e.g. MMTS,
NEM or IAA. We highly recommend evaluation of efficiency
for each type of blocking/alkylation reagent and biological
sample by e.g. western blot analysis. Additionally, complete
removal of unbound blocking reagent prior to reduction and
alkylation is required. Otherwise it may compete with
iodoTMT™ hampering the detection of target sulfhydryl
groups [50].
4.2.2. Differential alkylation of SNO, SOH and total cysteines
Differential alkylation is a balance between selectivity of
modification specific reductants and efficiency and stability
of alkylating chemistry. Despite widespread usage, the
selectivity of SNO reduction by ascorbate and SOH reduction
by arsenite has been controversial as reviewed in [2]. This is
due to the apparent concentration dependent changes in
reactivity of the reducing agents [48,54,55]. However, many
publications also demonstrate that non-selective reduction is
in the minority and often results from sample preparation
artefacts rather than from erroneous chemistry [48,56]. We
have observed GSNO and H2O2 induced formation of SNO
and SOH and tested the selectivity of ascorbate and arsenite
reduction and iodoTMT™ alkylation. Increased signal inten-
sity in oxidised samples under modification specific reduction
conditions as compared to the control confirm that the
reaction conditions used favoured the selectivity of SNO and
SOH reduction respectively. Although we believe that our
method is reliable in profiling alterations in cysteine modifi-
cations, it is only as reliable as the chemistry on which it is
based therefore we emphasise the need for further validation
with complementary methods like e.g. UV photolysis [57] or
anti-S-nitrosocysteine antibody for SNO and dimedone label-
ling for SOH [19,20].
In case of total cysteine labelling, we observed that in
addition to the use of an appropriate reagent concentration
the sequence of reduction/alkylation steps is also important.
Sequential reduction, reducing agent removal and alkylation
is essential for complete TCEP reduction. In the case of
modification specific reductions, reduction and alkylation
may be performed simultaneously [40]. Quenching and
removal of excess of the derivatization reagent are mandatory
prior to subsequent detection by selective affinity enrichment
as well as by western blot [40,58]. Partially neutralised tags
might cross-react with cysteines where MMTS is released
during reduction, artifactually increasing overall signal inten-
sity. We have observed this by western blot, and found that
500 mM DTT for quenching was sufficient to ameliorate this
effect (Supplementary Fig. S3B). 500 mM DTT provides excess
of free SH groups sufficient to neutralise unbound iodoTMT™
tags used for both SNO/SOH labelling (10 000 times excess of
SH groups over initial iodoTMT™ concentration used for
labelling) and for total cysteine labelling (200 times excess).
This is much higher than what is typically used in similar
studies [23].
4.2.3. Anti-TMT™ enrichment and alternative purification
strategies
Optimised enrichment schemes are powerful tools in modi-
fication specific proteomics [59]. Therefore selective enrich-
ment of iodoTMT™ labelled peptides is an important element
of the presented strategy. We have achieved 7% enrichment of
iodoTMT™ containing peptides with the anti-TMT™ antibody
which is in line with other antibody based pull-downs of
PTMs. For example, anti-(lysine) acetyl antibody typically
recovers 10–20% acetylated peptides [60]. Based on our results
it is clear that the overall enrichment strategy is severely
affected by the abundance of labelled peptides. We sought to
investigate whether orthogonal pre-fractionation (in this case
by HILIC chromatography) followed by extensive MS analysis
would compensate for lack of iodoTMT™-specific enrich-
ment. We used 100 times less material (20 μg) for HILIC
pre-fractionation compared to what was enriched with
anti-TMT™ resin. This amount of starting material could be
compatible with analysis of difficult to obtain biological
samples such as human tissue biopsies. Additionally, the
hands-on time for the HILIC method is much less than the
anti-TMT™ enrichment approaches. Even with 100 times less
material, a large number of iodoTMT™-containing peptides
were identified with relatively large proportion of uniquely
identified peptides. Poor overlap between anti-TMT™ enrich-
ment and HILIC pre-fractionation might be purely due to
stochastic nature of data-dependent acquisition and limited
number of technical replicates. Alternatively, it might be
due to orthogonal character of the two techniques. In any
case, the quantitative precision in the HILIC pre-fractionated
samples was severely compromised due to lower (1 order of
magnitude) reporter ion intensity. In the future improve-
ments should be sought aiming at increasing the number of
identified SNO/SOH modified peptides with focus on main-
taining high quality of the quantitative information without
demanding high sample quantities.
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4.2.4. Reproducibility and analytical precision
This is the first study aiming at global, quantitative profiling of
SNO and SOH changes in E. coli under mild oxidative stress. In
total we have identified 540 SNO/SOH sites. We achieved good
quantitative precision for both total cysteine labelling and SNO
across 3 biological replicates. However, analysis of SOH sites
was more challenging. Although we identified a reasonable
number of SOH sites, quantitative information was somewhat
compromised. One possible explanation is that near physiolog-
ical levels of oxidative stress imposed on our model did not
induce extensive SOH. This is also suggested by western blot
analysis. Alternatively, SOH might have undergone further
transformation to either reversible (SNO, disulfide bonds) or
irreversible modifications (S-sulfination, S-sulfonation) prior to
selective reduction and irreversible blocking with iodoTMT™.
4.3. Co-occurrence of SNO and SOH
Our data clearly show that in the vast majority of cases SNO
and SOH may occupy the same site, allowing for interaction
and cooperation between the modifications. This is in
agreement with the study of Kohr and co-workers who
established the relevance of interplay between SNO and
other cysteine modifications in the context of ischemia
reperfusion injury [29]. This is contrary to a previous work
which suggested that these modifications are almost exclu-
sive [22]. However, in this study modifications were identified
in parallel whereas we believe that in order to precisely detect
interplay between SNO and SOH a technique for simultaneous
detection of these modifications (such as SNO/SOH TMT)
must be used. Our method may be further adapted to address
other unanswered questions. To give a specific example, the
interplay between disulfide bond formation, glutathionylation
and SNO of Cys294, a known redox switch of the Mammalian
ATP synthase, has not been measured simultaneously in
quantitative manner [61].
4.4. Relative site occupancy
We observed that, with the notable exception of C184 from
respiratory nitrate reductase 1 beta chain, sites with high
SNO and SOH occupancy were not differentially regulated
between the two conditions. For instance, cysteine 147 of
NADP-specific glutamate dehydrogenase was the second most
heavily S-nitrosylated site, even though neither the protein
abundance nor the level of SNO was found differentially
regulated. This demonstrates that the presence or absence of
a modification is not necessarily indicative of its biological role
in a given system. These data support the idea that the extent of
cysteine modification may have a bearing on the role of that
modification [62]. For instance, a low abundance modification
may play a role in signalling, moderate abundance may
function as an antioxidant buffer and high abundance may
indicate oxidative damage.
4.5. SNO/SOH TMT strategy detects endogenous SNO and
SOH levels
Until today a large number of studies use experimental
models in which the oxidation is chemically induced with
e.g. GSNO [30,31]. In those models the oxidation level is
typically very high and often performed in denaturing
conditions where alterations in protein structure can readily
affect the potential of cysteine to undergo modification.
Therefore in this study we aimed to induce a mild level of
oxidative stress in E. coli to test if the SNO/SOH TMT method
was applicable where physiological levels of oxidative mod-
ifications are present. Protein expression analysis has con-
firmed that E. coli has switched its metabolism to anaerobic
growth in nitrate or fumarate. Our data are largely in
agreement with a microarray study of a similar model system
[6]. Of the genes up-regulated under nitrate growth and their
corresponding proteins in the present study, 68% agree in the
direction of regulation (Table S2). From these data we can also
observe only three proteins moderately increased in abun-
dance (Thiol peroxidase, Superoxide dismutase [Cu–Zn],
Alkyl hydroperoxide reductase subunit C) from the E. coli
antioxidant machinery, indicating that the oxidative insult
was indeed relatively mild.
In relation to oxidative modifications, our findings reflect
those of Murray et al. [63]. The relative abundance of the
majority of modified cysteines did not change between low
(fumarate growth) and mild (nitrate growth) oxidative stress.
The proteins with the most differential modification in our
study were NarH (C184-SOH); FrdA (Cys381 + 464-SNO) and
AdhE (Cys246, 370, 421-SNO). These, along with YncF, PepT
and FrdB all coordinate iron–sulfur clusters, use metal ions
as cofactors or are present in a complex which contains iron–
sulfur proteins. This is to be expected as proximity to metal
ions is a risk factor for oxidation. In concert with the multiple
observations of oxidatively modified metal coordinating
proteins, we observe a significant increase in abundance of
iron–sulfur cluster repair proteins YtfE, SufB and SufC in the
label-free data. This is a further indication that metal ion
proximal proteins are particularly susceptible to modification,
even under mild oxidative conditions.
Modification of NarH is localised to C184, which is one of
the cysteines coordinating one of the three iron–sulfur
clusters bound by NarH (Fig. 9). This modification could affect
the function of the protein as has been described for the
master regulator of the switch to anaerobic growth FNR [64].
Interestingly, although this site has one of the highest relative
site occupancy for both SNO and SOH, a significant change
between low andmild oxidative stress has been observed only
for SOH. It is likely that the high levels of SNO result from its
proximity to NarG which is the major source of SNO in E. coli
[6]. The high basal level of SNO could be the reason why no
significant increase in mild stress conditions is observed.
The modification to C246 of AdhE is particularly interesting
as this residue forms part of the enzyme active site and its
modification will certainly result in loss of enzyme activity.
These findings are in line with published data regarding
the susceptibility of aldehyde–alcohol dehydrogenase to oxida-
tive modifications, particularly to metal-catalysed oxidation
[65,66].
The SNO/SOH TMT technique presented was able to
produce quantitative, biologically relevant data relating to
SNO and SOH in a system under relatively mild oxidative
stress. These data also highlight the need for quantitative
information in such studies since high site occupancy does
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not necessarily equate to a site of modification which
responds to oxidative stress.
5. Conclusions
We present a new strategy for the analysis of protein SNO and
SOH modifications, identification, quantitation, modification
site localisation, correction of cysteine oxidation levels by
protein abundance changes and determination of relative
modification site occupancy in a single nLC-MSMS experi-
ment. Importantly, SNO/SOH TMT strategy allows for simul-
taneous analysis of SNO and SOH changes in samples with
physiological levels of oxidative stress. All based on commer-
cially available Iodoacetyl Tandem Mass Tag reagents
(iodoTMT™, Thermo Scientific).
SNO/SOH TMT is a powerful methodology for simulta-
neous screening of SNO and SOH alterations in response to
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Fig. 9 – SNO and SOH modifications of cysteine 184 residue in nitrate reductase A (NarH) of Escherichia coli. A. Structural model
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changes in ROS/RNS levels providing candidates for further
functional validation with alternative strategies.
This method creates completely new possibilities to study
the interdependence between SNO and SOH in biological
systems. It is anticipated that this approach, applied for the
analysis of biological questions will contribute to our under-
standing of how cellular redox is sensed and transduced to a
functional effect by protein thiol redox sensors. This will help
us better appreciate the role of oxidants in health and disease.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.jprot.2014.10.015.
Transparency document
The Transparency document associated with this article can
be found, in the online version.
Acknowledgements
Wewould like to express our gratitude to Dr. Veit Schwämmle
for help with significance analysis, Professor Peter Højrup
and Kristina Egede Budtz for amino acid composition analysis.
The authors were financially supported by — Sino-Danish
Center For Education and Research (KW), Augustinus Fonden,
Journ. nr. 13-3455 (KW), The Danish National Research
Foundation's Centre for Epigenetics DNRF82 (JW), Department
of Biochemistry andMolecular Biology, University of Southern
Denmark (ARW).
R E F E R E N C E S
[1] Bachi A, Dalle-Donne I, Scaloni A. Redox proteomics:
chemical principles, methodological approaches and
biological/biomedical promises. Chem Rev 2013;113:
596–698.
[2] Held JM, Gibson BW. Regulatory control or oxidative damage?
Proteomic approaches to interrogate the role of cysteine
oxidation status in biological processes. Mol Cell Proteomics
2012;11 R111.013037.
[3] Foster MW, Hess DT, Stamler JS. Protein S-nitrosylation in
health and disease: a current perspective. Trends Mol Med
2009;15:391–404.
[4] Murphy E, Kohr M, Menazza S, Nguyen T, Evangelista A, Sun J,
et al. Signaling by S-nitrosylation in the heart. J Mol Cell
Cardiol 2014;73:18–25.
[5] Gupta V, Carroll KS. Sulfenic acid chemistry, detection and
cellular lifetime. Biochim Biophys Acta 1840;2014:847–75.
[6] Seth D, Hausladen A, Wang YJ, Stamler JS. Endogenous
protein S-Nitrosylation in E coli: regulation by OxyR. Science
2012;336:470–3.
[7] Kettenhofen NJ, Wood MJ. Formation, reactivity, and
detection of protein sulfenic acids. Chem Res Toxicol 2010;
23:1633–46.
[8] Leonard SE, Carroll KS. Chemical ‘omics’ approaches for
understanding protein cysteine oxidation in biology. Curr
Opin Chem Biol 2011;15:88–102.
[9] Claiborne A, Yeh JI, Mallett TC, Luba J, Crane III EJ, Charrier V,
et al. Protein-sulfenic acids: diverse roles for an unlikely player
in enzyme catalysis and redox regulation. Biochemistry 1999;
38:15407–16.
[10] van Montfort RL, Congreve M, Tisi D, Carr R, Jhoti H. Oxidation
state of the active-site cysteine inprotein tyrosinephosphatase
1B. Nature 2003;423:773–7.
[11] Wood ZA, Poole LB, Karplus PA. Peroxiredoxin evolution and
the regulation of hydrogen peroxide signaling. Science 2003;
300:650–3.
[12] Antelmann H, Helmann JD. Thiol-based redox switches and
gene regulation. Antioxid Redox Signal 2011;14:1049–63.
[13] Giron P, Dayon L, Sanchez JC. Cysteine tagging for MS-based
proteomics. Mass Spectrom Rev 2011;30:366–95.
[14] Jaffrey SR, Snyder SH. The biotin switch method for the
detection of S-nitrosylated proteins. Sci STKE 2001;2001:pl1.
[15] Leichert LI, Gehrke F, Gudiseva HV, Blackwell T, Ilbert M,
Walker AK, et al. Quantifying changes in the thiol redox
proteomeuponoxidative stress in vivo. ProcNatl AcadSci U SA
2008;105:8197–202.
[16] Sethuraman M, McComb ME, Huang H, Huang S, Heibeck T,
Costello CE, et al. Isotope-coded affinity tag (ICAT) approach
to redox proteomics: identification and quantitation of
oxidant-sensitive cysteine thiols in complex protein
mixtures. J Proteome Res 2004;3:1228–33.
[17] Qu Z, Meng F, Bomgarden RD, Viner RI, Li J, Rogers JC, et al.
Proteomic quantification and site-mapping of S-nitrosylated
proteins using isobaric iodoTMT reagents. J Proteome Res
2014;13:3200–11.
[18] Saurin AT, Neubert H, Brennan JP, Eaton P. Widespread
sulfenic acid formation in tissues in response to hydrogen
peroxide. Proc Natl Acad Sci U S A 2004;101:17982–7.
[19] Benitez LV, AllisonWS. The inactivation of the acyl phosphatase
activity catalyzed by the sulfenic acid form of glyceraldehyde
3-phosphate dehydrogenase by dimedone and olefins. J Biol
Chem 1974;249:6234–43.
[20] Poole LB, Zeng BB, Knaggs SA, Yakubu M, King SB. Synthesis
of chemical probes to map sulfenic acid modifications on
proteins. Bioconjug Chem 2005;16:1624–8.
[21] Reddie KG, Seo YH, Muse Iii WB, Leonard SE, Carroll KS. A
chemical approach for detecting sulfenic acid-modified
proteins in living cells. Mol Biosyst 2008;4:521–31.
[22] Leonard SE, Reddie KG, Carroll KS. Mining the thiol proteome
for sulfenic acid modifications reveals new targets for
oxidation in cells. ACS Chem Biol 2009;4:783–99.
[23] Garcia-Santamarina S, Boronat S, Espadas G, Ayte J, Molina H,
Hidalgo E. The oxidized thiol proteome in fission yeast—
optimization of an ICAT-based method to identify H2O2-
oxidized proteins. J Proteomics 2011;74:2476–86.
[24] Martinez-Acedo P, Nunez E, Gomez FJ, Moreno M, Ramos E,
Izquierdo-Alvarez A, et al. A novel strategy for global analysis
of the dynamic thiol redox proteome. Mol Cell Proteomics
2012;11:800–13.
[25] Garcia-Santamarina S, Boronat S, Domenech A, Ayte J, Molina
H, Hidalgo E. Monitoring in vivo reversible cysteine oxidation
in proteins using ICAT and mass spectrometry. Nat Protoc
2014;9:1131–45.
[26] Murray CI, Van Eyk JE. A twist on quantification: measuring the
site occupancy of S-nitrosylation. Circ Res 2012;111:1253–5.
[27] Doulias PT, Tenopoulou M, Raju K, Spruce LA, Seeholzer SH,
Ischiropoulos H. Site specific identification of endogenous
S-nitrosocysteine proteomes. J Proteomics 2013;92:195–203.
[28] Kohr MJ, Aponte A, Sun J, Gucek M, Steenbergen C, Murphy E.
Measurement of S-nitrosylation occupancy in themyocardium
with cysteine-reactive tandemmass tags: short
communication. Circ Res 2012;111:1308–12.
[29] Kohr MJ, Sun J, Aponte A, Wang G, Gucek M, Murphy E, et al.
Simultaneous measurement of protein oxidation and S-
nitrosylation during preconditioning and ischemia/reperfusion
injury with resin-assisted capture. Circ Res 2011;108:418–26.
[30] Feng JH, Jing FB, Fang H, Gu LC, Xu WF. Expression,
purification, and S-nitrosylation of recombinant histone
deacetylase 8 in Escherichia coli. Biosci Trends 2011;5:17–22.
433J O U R N A L O F P R O T E O M I C S 1 1 3 ( 2 0 1 5 ) 4 1 5 – 4 3 4
[31] Shi Q, Feng J, Qu H, Cheng YY. A proteomic study of S-
nitrosylation in the rat cardiac proteins in vitro. Biol Pharm
Bull 2008;31:1536–40.
[32] Pan KT, Chen YY, Pu TH, Chao YS, Yang CY, Bomgarden RD,
et al. Mass spectrometry-based quantitative proteomics for
dissecting multiplexed redox cysteine modifications in nitric
oxide-protected cardiomyocyte under hypoxia. Antioxid
Redox Signal 2014;20:1365–81.
[33] Neidhardt FC, Bloch PL, Smith DF. Culture medium for
enterobacteria. J Bacteriol 1974;119:736–47.
[34] Gobom J, Nordhoff E, Mirgorodskaya E, Ekman R, Roepstorff P.
Sample purification and preparation technique based on
nano-scale reversed-phase columns for the sensitive analysis
of complex peptide mixtures by matrix-assisted laser
desorption/ionization mass spectrometry. J Mass Spectrom
1999;34:105–16.
[35] Wojdyla K, Rogowska-Wrzesinska A, Wrzesinski K,
Roepstorff P. Mass spectrometry based approach for
identification and characterisation of fluorescent proteins
from marine organisms. J Proteomics 2011;75:44–55.
[36] The Global Proteome Machine. The common repository of
adventitious proteins, cRAP. http://www.thegpm.org/cRAP/
index.html.
[37] Leon IR, Schwammle V, Jensen ON, Sprenger RR. Quantitative
assessment of in-solution digestion efficiency identifies
optimal protocols for unbiased protein analysis. Mol Cell
Proteomics 2013;12:2992–3005.
[38] Masuda T, Tomita M, Ishihama Y. Phase transfer
surfactant-aided trypsin digestion for membrane proteome
analysis. J Proteome Res 2008;7:731–40.
[39] Verano-Braga T, Miethling-Graff R, Wojdyla K,
Rogowska-Wrzesinska A, Brewer JR, Erdmann H, et al.
Insights into the cellular response triggered by silver
nanoparticles using quantitative proteomics. ACS Nano 2014;
8:2161–75.
[40] Thermo Scientific Instructions. Iodoacetyl tandemmass TagTM
(iodoTMT™) reagents. http://www.piercenet.com/instructions/
2162387.pdf.
[41] Kim SO, Merchant K, Nudelman R, Beyer Jr WF, Keng T,
DeAngelo J, et al. OxyR: a molecular code for redox-related
signaling. Cell 2002;109:383–96.
[42] Lin A, Wang Y, Tang J, Xue P, Li C, Liu L, et al. Nitric oxide and
protein S-nitrosylation are integral to hydrogen
peroxide-induced leaf cell death in rice. Plant Physiol 2012;
158:451–64.
[43] Htet Hlaing K, Clement MV. Formation of protein
S-nitrosylation by reactive oxygen species. Free Radic Res
2014;1–37.
[44] Dujovne CA. Liver cell culture toxicity and surfactant potency
of erythromycin derivatives. Toxicol Appl Pharmacol 1975;32:
11–20.
[45] Halliwell B, Gutteridge JMC. Free radicals in biology and
medicine. 4th ed. Oxford. New York: Oxford University Press;
2007.
[46] Sun MA,Wang Y, Cheng H, Zhang Q, GeW, Guo D. RedoxDB—
a curated database for experimentally verified protein
oxidative modification. Bioinformatics 2012;28:2551–2.
[47] Ow SY, Salim M, Noirel J, Evans C, Rehman I, Wright PC.
iTRAQ underestimation in simple and complex mixtures:
“the good, the bad and the ugly”. J ProteomeRes 2009;8:5347–55.
[48] Forrester MT, Foster MW, Benhar M, Stamler JS. Detection of
protein S-nitrosylation with the biotin-switch technique.
Free Radic Biol Med 2009;46:119–26.
[49] Guo J, Gaffrey MJ, Su D, Liu T, Camp II DG, Smith RD, et al.
Resin-assisted enrichment of thiols as a general strategy
for proteomic profiling of cysteine-based reversible
modifications. Nat Protoc 2014;9:64–75.
[50] Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P,
Snyder SH. Protein S-nitrosylation: a physiological signal for
neuronal nitric oxide. Nat Cell Biol 2001;3:193–7.
[51] Smith DJ, Maggio ET, Kenyon GL. Simple alkanethiol groups
for temporary blocking of sulfhydryl groups of enzymes.
Biochemistry 1975;14:766–71.
[52] Partis MD. Cross-linking of protein by ω-maleimido alkanoyl
N-hydroxysuccinimido esters. J Protein Chem 1983;2:263–77.
[53] Hansen RE, Winther JR. An introduction to methods for
analyzing thiols and disulfides: reactions, reagents, and
practical considerations. Anal Biochem 2009;394:147–58.
[54] Holmes AJ, Williams DLH. Reaction of ascorbic acid with
S-nitrosothiols: clear evidence for two distinct reaction
pathways. J Chem Soc Perkin Trans 2 2000:1639–44.
[55] Wang X, Kettenhofen NJ, Shiva S, Hogg N, Gladwin MT.
Copper dependence of the biotin switch assay: modified
assay for measuring cellular and blood nitrosated proteins.
Free Radic Biol Med 2008;44:1362–72.
[56] Murray CI, Van Eyk JE. Chasing cysteine oxidativemodifications:
proteomic tools for characterizing cysteine redox status. Circ
Cardiovasc Genet 2012;5:591.
[57] Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, et al.
Nitric oxide circulates in mammalian plasma primarily as an
S-nitroso adduct of serum albumin. Proc Natl Acad Sci U S A
1992;89:7674–7.
[58] Thermo Scientific Instructions. Pierce S-nitrosylation western
blot kit. http://www.piercenet.com/product/s-nitrosylation-
western-blot-kit.
[59] Mertins P, Qiao JW, Patel J, Udeshi ND, Clauser KR,Mani DR, et al.
Integrated proteomic analysis of post-translational
modifications by serial enrichment. Nat Methods 2013;10:634–7.
[60] Guan KL, Yu W, Lin Y, Xiong Y, Zhao S. Generation of
acetyllysine antibodies and affinity enrichment of acetylated
peptides. Nat Protoc 2010;5:1583–95.
[61] Wang SB, Foster DB, Rucker J, O'Rourke B, Kass DA, Van Eyk
JE. Redox regulation of mitochondrial ATP synthase:
implications for cardiac resynchronization therapy. Circ Res
2011;109:750–7.
[62] Thamsen M, Jakob U. The redoxome: proteomic analysis of
cellular redox networks. Curr Opin Chem Biol 2011;15:113–9.
[63] Murray CI, Uhrigshardt H, O'Meally RN, Cole RN, Van Eyk JE.
Identification and quantification of S-nitrosylation by
cysteine reactive tandem mass tag switch assay. Mol Cell
Proteomics 2012;11 M111 013441.
[64] Crack JC, Stapleton MR, Green J, Thomson AJ, Le Brun NE.
Mechanism of [4Fe-4S](Cys)4 cluster nitrosylation is
conserved among NO-responsive regulators. J Biol Chem
2013;288:11492–502.
[65] Moon KH, Abdelmegeed MA, Song BJ. Inactivation of cytosolic
aldehyde dehydrogenase via S-nitrosylation in
ethanol-exposed rat liver. FEBS Lett 2007;581:3967–72.
[66] Tamarit J, Cabiscol E, Ros J. Identification of the major
oxidatively damaged proteins in Escherichia coli cells exposed
to oxidative stress. J Biol Chem 1998;273:3027–32.
434 J O U R N A L O F P R O T E O M I C S 1 1 3 ( 2 0 1 5 ) 4 1 5 – 4 3 4
